🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

According to the social media company, the service has removed violative content and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, populated with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at residence.

Within minutes of entering one group, a vendor posted contact information, where most purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or previous experience.

Product Information and Costs

Inside these groups, messages display black plastic packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram said it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.